Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02748564 |
| Title | Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Rutgers, The State University of New Jersey |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |